HALO logo
ACW
Actinogen Medical Limited

ACW · Actinogen Medical Limited

0.008

AUD
-0.037 (-82.222%)
19/11/2026 04:10:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$174.14M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 19/11/2026 04:10:00 PM

Price StockChart

Description

Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.

  • All-Companies
  • All-Consensus
  • Big Candle (Realtime)
  • Extreme Oversold (Realtime)
  • GROWTH AUS
  • HALO Balance Sheet
  • HALO Ords
  • Near Support (Realtime)
  • Volume Spike (Realtime)

Key Fundamentals

EPS 3 yr Growth

-19.30%

EBITDA Margin

N/A

Operating Cashflow

-$18m

Free Cash Flow Return

-87.80%

ROIC

-76.90%

Interest Coverage

-59.40

Quick Ratio

3.40

Performance

52 weeks range

Low 0 - 0.07

Trade Value (12mth)

AU$50,085.00

1 week

4.65%

1 month

4.65%

YTD

-31.82%

1 year

-13.46%

All time high

0.84

Additional Data

Shares Outstanding (Fully Diluted)

3,303m

HALO Sector

Healthcare

Next Company Report Date

30-Aug-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
19 November 26ASXD
19 November 26ASXD
17 November 26ASXD
13 November 26ASXD
13 November 26ASXD

Key Stakeholders

NameTitle
Steven G. GourlayIndividual
Guillermo Cesar OrselliIndividual
Old College Capital Holdings Ltd.Private Company
Sve Capital Pty Ltd.Private Company
Geoff Edward Duncan BrookeIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Actinogen Medical Limited (ACW:ASX)?
Halo FAQ
The current share price of Actinogen Medical Limited (ACW:ASX) is AUD$0.01.
2
What is the 52-week high share price for Actinogen Medical Limited (ACW:ASX)?
Halo FAQ
The 52-week high share price for Actinogen Medical Limited (ACW:ASX) is AUD$0.07.
3
What is the 52-week low share price for Actinogen Medical Limited (ACW:ASX)?
Halo FAQ
The 52-week low share price for Actinogen Medical Limited (ACW:ASX) is AUD$0.00.
4
What is the dividend yield for Actinogen Medical Limited (ACW:ASX)?
Halo FAQ
Actinogen Medical Limited (ACW:ASX) does not pay a dividend.
5
What was Actinogen Medical Limited (ACW:ASX) last dividend payment?
Halo FAQ
Actinogen Medical Limited (ACW:ASX) does not pay a dividend.
6
What is the franking level for Actinogen Medical Limited (ACW:ASX)?
Halo FAQ
Actinogen Medical Limited (ACW:ASX) has a franking level of 0.00%.
7
In which sector is Actinogen Medical Limited (ACW:ASX) classified?
Halo FAQ
Actinogen Medical Limited (ACW:ASX) is classified in the Healthcare.